These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26048809)

  • 1. Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity.
    Peters HL; Jochmans D; de Wilde AH; Posthuma CC; Snijder EJ; Neyts J; Seley-Radtke KL
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2923-6. PubMed ID: 26048809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleoside analogues for the treatment of coronavirus infections.
    Pruijssers AJ; Denison MR
    Curr Opin Virol; 2019 Apr; 35():57-62. PubMed ID: 31125806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-coV).
    Chu CK; Gadthula S; Chen X; Choo H; Olgen S; Barnard DL; Sidwell RW
    Antivir Chem Chemother; 2006; 17(5):285-9. PubMed ID: 17176633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.
    de Wilde AH; Jochmans D; Posthuma CC; Zevenhoven-Dobbe JC; van Nieuwkoop S; Bestebroer TM; van den Hoogen BG; Neyts J; Snijder EJ
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4875-84. PubMed ID: 24841269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-Molecule Antiviral β-d-
    Agostini ML; Pruijssers AJ; Chappell JD; Gribble J; Lu X; Andres EL; Bluemling GR; Lockwood MA; Sheahan TP; Sims AC; Natchus MG; Saindane M; Kolykhalov AA; Painter GR; Baric RS; Denison MR
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
    Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
    Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.
    Persoons L; Vanderlinden E; Vangeel L; Wang X; Do NDT; Foo SC; Leyssen P; Neyts J; Jochmans D; Schols D; De Jonghe S
    Antiviral Res; 2021 Sep; 193():105127. PubMed ID: 34217752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses
    Stone NE; Jaramillo SA; Jones AN; Vazquez AJ; Martz M; Versluis LM; Raniere MO; Nunnally HE; Zarn KE; Nottingham R; Ng KR; Sahl JW; Wagner DM; Knudsen S; Settles EW; Keim P; French CT
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506.
    Carbajo-Lozoya J; Müller MA; Kallies S; Thiel V; Drosten C; von Brunn A
    Virus Res; 2012 Apr; 165(1):112-7. PubMed ID: 22349148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses.
    Adedeji AO; Singh K; Kassim A; Coleman CM; Elliott R; Weiss SR; Frieman MB; Sarafianos SG
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4894-8. PubMed ID: 24841268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model.
    de Wilde AH; Falzarano D; Zevenhoven-Dobbe JC; Beugeling C; Fett C; Martellaro C; Posthuma CC; Feldmann H; Perlman S; Snijder EJ
    Virus Res; 2017 Jan; 228():7-13. PubMed ID: 27840112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral Activities of Halogenated Emodin Derivatives against Human Coronavirus NL63.
    Horvat M; Avbelj M; Durán-Alonso MB; Banjanac M; Petković H; Iskra J
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
    Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
    J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses.
    Martinez DR; Moreira FR; Catanzaro NJ; Diefenbacher MV; Zweigart MR; Gully KL; De la Cruz G; Brown AJ; Adams LE; Yount B; Baric TJ; Mallory ML; Conrad H; May SR; Dong S; Scobey DT; Nguyen C; Montgomery SA; Perry JK; Babusis D; Barrett KT; Nguyen AH; Nguyen AQ; Kalla R; Bannister R; Feng JY; Cihlar T; Baric RS; Mackman RL; Bilello JP; Schäfer A; Sheahan TP
    Sci Transl Med; 2024 May; 16(748):eadj4504. PubMed ID: 38776389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Frameshifting Inhibitor Having Antiviral Activity against Zoonotic Coronaviruses.
    Ahn DG; Yoon GY; Lee S; Ku KB; Kim C; Kim KD; Kwon YC; Kim GW; Kim BT; Kim SJ
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flexibility as a Strategy in Nucleoside Antiviral Drug Design.
    Peters HL; Ku TC; Seley-Radtke KL
    Curr Med Chem; 2015; 22(34):3910-21. PubMed ID: 26282942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing Nucleoside Analogs for Human Coronaviruses.
    Zandi K; Amblard F; Musall K; Downs-Bowen J; Kleinbard R; Oo A; Cao D; Liang B; Russell OO; McBrayer T; Bassit L; Kim B; Schinazi RF
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33122172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection.
    Dyall J; Coleman CM; Hart BJ; Venkataraman T; Holbrook MR; Kindrachuk J; Johnson RF; Olinger GG; Jahrling PB; Laidlaw M; Johansen LM; Lear-Rooney CM; Glass PJ; Hensley LE; Frieman MB
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4885-93. PubMed ID: 24841273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL
    Kumar V; Shin JS; Shie JJ; Ku KB; Kim C; Go YY; Huang KF; Kim M; Liang PH
    Antiviral Res; 2017 May; 141():101-106. PubMed ID: 28216367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human coronavirus NL63 infection at early stages of the replication cycle.
    Pyrc K; Bosch BJ; Berkhout B; Jebbink MF; Dijkman R; Rottier P; van der Hoek L
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2000-8. PubMed ID: 16723558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.